Wyeth Pharmaceutical Patient Assistance Foundation

Summary

Wyeth Pharmaceuticals was founded in by brothers John and Frank Wyeth in Philadelphia, Pennsylvania, 1822. Wyeth Pharmaceuticals was one of the first companies to mass-produce medications shortly after the Civil War. In their almost 200 years as a pharmaceutical company, Wyeth has progressed forward through their advanced research and development which focuses on small molecules, vaccines, and biotechnology. With their expertise, Wyeth Pharmaceuticals has become a global authority in the areas of women’s health care, neuroscience, musculoskeletal disorders, cardiovascular therapy, vaccines and infectious disease, hemophilia, immunology and oncology. With over 60 new therapies in their pipeline, Wyeth Pharmaceuticals has proven their ability to delve deeper into both old and new fields to provide the best products possible for patients worldwide.

Eligibility

Wyeth Pharmaceutical Patient Assistance Foundation, a patient assistance program provided by Wyeth Pharmaceuticals, offers the medications listed to the right at no cost for up to 90 days (60 for Protonix) to those who are eligible for the program. Eligibility is based off of the following requirements:

- You must be a citizen of the United States or its Territories.

- You must not be covered by private or public health insurance.

- Your income must be less than or equal to 200% of the Federal Poverty Guideline for the size of your household (see chart below).

Those eligible for Medicare Part D but not enrolled may still be eligible.